The World Health Organization (WHO), in their 2022 report, identified cancer as one of the
leading causes of death, accounting for about 16% of deaths worldwide. The Cancer …

Artificial intelligence (AI) is rapidly reshaping cancer research and personalized clinical
care. Availability of high-dimensionality datasets coupled with advances in high …

Cancer significantly contributes to global mortality, with 9.3 million annual deaths. To
alleviate this burden, the utilization of artificial intelligence (AI) applications has been …

Clinical oncology is experiencing rapid growth in data that are collected to enhance cancer
care. With recent advances in the field of artificial intelligence (AI), there is now a …

Artificial intelligence (AI) has been available in rudimentary forms for many decades. Early AI
programs were successful in niche areas such as chess or handwriting recognition …

The promise of highly personalized oncology care using artificial intelligence (AI)
technologies has been forecasted since the emergence of the field. Cumulative advances …

Cancer is a major medical problem worldwide. Due to its high heterogeneity, the use of the
same drugs or surgical methods in patients with the same tumor may have different curative …

Recently, a wide spectrum of artificial intelligence (AI)–based applications in the broader
categories of digital pathology, biomarker development, and treatment have been explored …

Over the past decade, artificial intelligence (AI) has contributed substantially to the resolution
of various medical problems, including cancer. Deep learning (DL), a subfield of AI, is …

Several factors, including advances in computational algorithms, the availability of high-
performance computing hardware, and the assembly of large community-based databases …